All Company News
Integra LifeSciences Announces Leadership Transition
Stuart M. Essig, chairman of Integra’s Board of Directors, has been appointed president and chief executive officer, effective May 1, 2026. Mr. Essig will continue to serve as chairman. He succeeds Mojdeh Poul who is pursuing other opportunities. Integra also announced that Michael McBreen, currently executive vice president, president, Codman Specialty Surgical, has been appointed chief commercial officer.
Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results
Integra LifeSciences reported financial results for the fourth quarter and full year ended December 31, 2025.
Integra LifeSciences Announces Key Executive Leadership Appointments
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access
Integra LifeSciences Reports Third Quarter 2025 Financial Results
Integra LifeSciences reported financial results for the third quarter ending September 30, 2025. Highlights include:
Championing Voices that Shape the Future
Integra Named on MedTech Big 100 List
Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer
Committed to Helping Patients with Hydrocephalus
Integra LifeSciences Reports Second Quarter 2025 Financial Results
Integra LifeSciences Reports First Quarter 2025 Financial Results
